Literature DB >> 21041795

Primary care research and clinical practice: cardiovascular disease.

N Mavaddat1, J Mant.   

Abstract

Improvement in survival of patients with cardiovascular diseases and an ageing population mean that management of cardiovascular conditions remains an important challenge for primary care. Traditionally cardiovascular research has been based largely in secondary or tertiary care settings. The majority of care for people with cardiovascular diseases, however, takes place in the community and within primary care. In recent years, progress has been made in conducting cardiovascular research within primary care itself. A number of different methodologies including large prospective cohort studies, randomised controlled trials, and qualitative designs have been used to inform optimal cardiovascular disease management for those in the community. Some of the recent research evidence in primary care in three areas of cardiovascular medicine--atrial fibrillation, heart failure, and cardiovascular risk prediction and management--are discussed in this review. These seek to demonstrate the contribution made by primary care research to the management of cardiovascular diseases.

Entities:  

Mesh:

Year:  2010        PMID: 21041795     DOI: 10.1136/pgmj.2009.094771

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  2 in total

1.  Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians.

Authors:  Carole Decker; Linda Garavalia; Brian Garavalia; Teresa Simon; Matthew Loeb; John A Spertus; William C Daniel
Journal:  J Multidiscip Healthc       Date:  2012-06-13

2.  Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC).

Authors:  William Hinton; Andrew McGovern; Rachel Coyle; Thang S Han; Pankaj Sharma; Ana Correa; Filipa Ferreira; Simon de Lusignan
Journal:  BMJ Open       Date:  2018-08-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.